Prev：Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway(A23310-3)
Next：DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing(A25012-30.9)
